Exploratory research to investigate the single nucleotide polymorphisms (SNP) which can predict oxaliplatin-induced neuropathy

Exploratory research to investigate the single nucleotide polymorphisms (SNP) which can predict oxaliplatin-induced neuropathy - Oxaliplatin-induced neuropathy and SNP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001231

Enrollment

Registered

2008-07-08

Start date

2008-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Histologically confirmed colorectal cancer patients whose oxaliplatin-related neurotoxicity was evaluated based on DEB-NTC after 6 courses of treatment 2.Written informed consent

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
To investigate the single nucleotide polymorphisms correlated with oxaliplatin-induced neuropathy	—

Secondary

Measure	Time frame
To investigate the single nucleotide polymorphisms correlated with the efficacy of oxaliplatin-based chemotherapy	—

Countries

Japan

Outcome results